Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C35H49NO10 |
Molecular Weight | 643.7643 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@](\C=C\CCCCCCC(=O)CCCCCCC)(C(=O)N[C@@H](CC1=CC=C(OCC#CC)C=C1)C(O)=O)[C@@](O)(CC(O)=O)C(O)=O
InChI
InChIKey=RZHKGHCZVMTIDL-XSRFUOEWSA-N
InChI=1S/C35H49NO10/c1-3-5-7-10-13-16-27(37)17-14-11-8-9-12-15-18-29(35(45,34(43)44)25-31(38)39)32(40)36-30(33(41)42)24-26-19-21-28(22-20-26)46-23-6-4-2/h15,18-22,29-30,45H,3,5,7-14,16-17,23-25H2,1-2H3,(H,36,40)(H,38,39)(H,41,42)(H,43,44)/b18-15+/t29-,30+,35+/m1/s1
Molecular Formula | C35H49NO10 |
Molecular Weight | 643.7643 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 1 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:32:26 GMT 2023
by
admin
on
Sat Dec 16 11:32:26 GMT 2023
|
Record UNII |
KG6QPD6JM9
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
827034-92-4
Created by
admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
|
PRIMARY | |||
|
5278643
Created by
admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
|
PRIMARY | |||
|
KG6QPD6JM9
Created by
admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
|
PRIMARY | |||
|
300000042534
Created by
admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
|
PRIMARY | |||
|
744208-75-1
Created by
admin on Sat Dec 16 11:32:26 GMT 2023 , Edited by admin on Sat Dec 16 11:32:26 GMT 2023
|
NON-SPECIFIC STEREOCHEMISTRY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Class: Small molecule; Mechanism of Action: Hepatitis C virus replication inhibitor; Highest Development Phase: Preclinical for Hepatitis C; Most Recent Events: 23 Aug 2012 Preclinical development is ongoing in Japan, 03 Apr 2009 Preclinical development is ongoing in Japan,
09 Dec 2005 Preclinical trials in Hepatitis C in Japan (unspecified route)
|